SOUTH CAROLINA CLINICAL & TRANSLATIONAL RESEARCH INSTITUTE
SCTR will facilitate new and innovative, interdisciplinary, high-impact translational research with emphasis on diseases demonstrating significant prevalence in South Carolina. SCTR supports applications across the translational spectrum - from basic science to population health - including patient-centered and community-engaged applications as well as applications from Early Career Investigators to shorten the time to research independence.
Learn more about SCTR's Pilot Project Program impact here
Click here to view SCTR Funded Pilot Projects
NEW NIH Requirements for Scientific Rigor and Transparency
|Biostatistics and Research Design|
Budget and Justification
|Regulatory (eg. IRB, consents)||Intellectual Property|
Community Engagement and
|Technology Development and Intellectual Property||Clinical Data Warehouse||Study Feasibility & Recruitment|
(for clinical trials)
SCTR INSTITUTE/MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
Request for Applications (RFA) for Technology Development Grants
SCTR’s Therapeutics Translation Core (TTC), in conjunction with the MUSC Foundation
AWARD AMOUNT: Up to $25,000 in direct costs for 6 months.
Pre-Application Opens: Sept 4, 2017
Pre-Application Due: Sept 18, 2017
Invitation to Submit Full Application: Sept 25, 2017
Full Application Due: Oct 27, 2017
Notice of Award: Nov 10, 2017
Contact: Ford Simmons, MLIS at (843) 792-2994 or email@example.com.
SCTR INSTITUTE PILOT PROJECTS
SCTR Discovery Grants
SCTR’s Pilot Project Program aims to facilitate new and innovative, high-impact translational research. The primary objectives of pilot funding are to support new and innovative, scientifically meritorious projects to collect critical preliminary data for submission of extramural grant applications and to publish research findings. We place a premium on interdisciplinary team science and new collaborations. Therefore if you are applying for this grant mechanism it is required to have an interdisciplinary team collaboration with at least one Co-Investigator/Collaborator from a different discipline.
AWARD AMOUNT: Up to $25,000 in direct costs per 12-month period
Pre-application Submission (REQUIRED) is now closed.
Pre-applicants will be notified with the decisions on whether to submit full applications or not.
Full Application Due: by noon on Friday, (EST), September 29
*Once an application is submitted, you should see a copy of the application. At that time, you should correct any errors to submit/resubmit. Incomplete, late applications and/or applications not responsive to the RFA will not be accepted or reviewed. Once an application is properly submitted, inform the Program at firstname.lastname@example.org. We will confirm whether your application has been received. However, we will not add/edit an application once submitted.
Contact: Dayan Ranwala, PhD, Associate Director for Pilot Project Program and Team Science Program at email@example.com
High Innovation-High Reward Pilots
CENTER FOR GENOMIC MEDICINE (CGM)
PILOT AND FEASIBILITY PROJECT PROGRAM RFA
The MUSC CGM is launching its third pilot project initiative with the goal of developing new paths of research in genomic medicine that make use of genomics technologies, including next generation sequencing and bioinformatics capabilities on campus. The overall aim of this pilot initiative is to stimulate basic, translational, and clinical research in genomic medicine and genetics for faculty, staff, and students within MUSC who have become members in the CGM.
The main objective of the program is to promote the growth of the CGM through the development of new extramural grant funding, utilization of critical technologies and CGM Core services to allow investigators to obtain genomic data, including NGS based data, to be used in currently pending or future extramural grant applications.
AWARD AMOUNT: Up to $25,000 from the CGM with required $:$ matching funds from the another Department/Center to total up to $50,000 (Direct costs only)
Letter of Intent (LOI) Due: By 5PM on Friday, September 1, 2017 (EST); LOI should be sent to Ginny Davis at firstname.lastname@example.org*
Application Due Date: By 5PM on Monday, October 16, 2017 (EST)
Earliest Anticipated Funding Date: December 1, 2017
*Only invited applicants should submit the full application using the ‘Appropriate Apply’ button.
Program Contacts: Stephen P. Ethier, PhD, Email: email@example.com; Phone: 843-876-2298
Administrative Questions: Virginia Davis; Email: firstname.lastname@example.org; Phone: 843-876-2298
- To provide help for the MUSC investigators who are submitting extramural grant applications.
- To increase the quality of the extramural grant application submissions and success of getting them funded.
SCTR Internal Scientific Review of Extramural Grant Application
External Review of Extramural Grant Application
|To facilitate timely turnaround of the reviews, please submit all required components of the application, and other required information as listed in the "Information" sections.|
Upon submission of an application (including the information above) to the SCTR application system, please notify Dayan Ranwala, PhD, via email (email@example.com).
MUSC ONLINE LIBRARY OF SUCCESSFULLY FUNDED EXTRAMURAL RESEARCH PROPOSALS
2007 - 2016 Funded Pilot Projects - PDF
|Christine Carr, MD|
The HEART Pathway: A Learning Health System Project, Translating Evidence to Practice Across the Carolinas
|Christine Cooper, MD|
Brain Circuitry Changes in Vascular Parkinsonism
|Carla Danielson, PhD|
Psychiatry and Behavioral Sciences
Trait Loci, PTSD, and Hazardous Alcohol Use
Monika Gooz, MD, PhD
Rochelle Hanson, PhD
Using Team Science to Integrate Primary Care and Behavioral Health for Trauma-Impacted Youth
Kyu-Ho Lee, MD, PhD
A Unique Mouse Model of Preeclampsia
|Lisa McTeague, PhD|
Psychiatry and Behavioral Sciences
Extinguishing Fear and Craving: Neuromodulating Shared Circuits
Anna-Liisa Nieminen, PhD
Mechanisms of Mitochrondrial Iron Uptake - Potential New Therapeutic Target
Alicia Privette, PhD
Information Technology for Teamwork and Communication In Trauma (IT-TACIT)
|Kit Simpson, DrPH|
Healthcare Leadership & Management
Discovering Variations in Use and Outcomes in Three Stroke Rehabilitation Settings for Populations Defined by ADL, Age, Race, and Geography
|Carol Wagner, MD|
Vitamin D Dependent Effects on Milk Fat Globule Membrane Structure and Composition
|Perry V Halushka, PhD, MD|
|Kevin Gray, MD|
Associate Program Director
|Christine Turley, MD|
Associate Program Director
|Dayan Ranwala, PhD|